Diaceutics stock rises on "strong" first half and contract expansion
(Alliance News) - Diaceutics PLC on Tuesday said its momentum was "strong" in its first half, and maintained its confidence in hitting full-year targets for 2025. Read More
Price | 144.50p on 17-09-2025 | at 18:35:06
---|---|
Change | -3.50p -2.36% |
Buy | 146.00p |
Sell | 143.00p |
Last Trade: | Unknown 3,000.00 at 144.50p |
Day's Volume: | 30,500 |
Last Close: | 144.50p |
Open: | 144.00p |
ISIN: | GB00BJQTGV64 |
Day's Range | 144.00p - 144.50p |
52wk Range: | 107.50p - 151.00p |
Market Capitalisation: | £122.17m |
VWAP: | 145.2877p |
Shares in Issue: | 84.55m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Diaceutics (DXRX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 3,000 | 144.50p | OTC Trade |
17:06:53 - 17-Sep-25 |
Buy* | 1,500 | 146.00p | Ordinary |
15:24:51 - 17-Sep-25 |
Buy* | 3,000 | 145.99p | Ordinary |
15:17:25 - 17-Sep-25 |
Buy* | 37 | 146.00p | SI Trade |
15:16:21 - 17-Sep-25 |
Sell* | 2 | 143.00p | SI Trade |
15:16:21 - 17-Sep-25 |
Buy* | 13 | 146.00p | SI Trade |
15:16:21 - 17-Sep-25 |
Buy* | 3,000 | 146.00p | Ordinary |
15:16:17 - 17-Sep-25 |
Sell* | 1,508 | 144.25p | Ordinary |
15:10:26 - 17-Sep-25 |
Unknown* | 5,000 | 144.50p | Ordinary |
15:03:05 - 17-Sep-25 |
Unknown* | 1,500 | 144.50p | Ordinary |
14:22:42 - 17-Sep-25 |
Diaceutics (DXRX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
11th Sep 2025 7:00 am | RNS | Notice of Results |
9th Sep 2025 10:47 am | RNS | Holding(s) in Company |
2nd Sep 2025 7:00 am | RNS | PDMR Shareholding/Share Incentive Plan and TVR |
11th Aug 2025 10:58 am | RNS | Holding(s) in Company |
5th Aug 2025 7:00 am | RNS-R | Diaceutics at Canaccord Genuity Growth Conference |
30th Jul 2025 7:00 am | RNS | PDMR Shareholding/Share Incentive Plan and TVR |
29th Jul 2025 7:00 am | RNS-R | Diaceutics Announces Key Leadership Appointment |
25th Jul 2025 12:15 pm | RNS | Holding(s) in Company |
23rd Jul 2025 7:00 am | RNS | Issue of Share Options / PDMR Shareholdings |
22nd Jul 2025 7:00 am | RNS | 22% Revenue Growth H125 representing 3-yr CAGR 25% |